Genome & Company
₩3,370
0
-₩130-3.71% 06:17 Today
Statistics
Day High
3,500
Day Low
3,295
52W High
10,180
52W Low
2,745
Volume
255,953
Avg. Volume
480,700
Mkt Cap
117.59B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Financials
-26.14%Profit Margin
Unprofitable24.59BRevenue
-6.43BNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Genome & Company, a clinical stage biotechnology company, researches and develops novel-targeted immuno-oncology therapeutics in the field of immuno-oncology, skin diseases, and autism in South Korea, Asia, Europe, South America, North America, and internationally. Its lead product candidate is GEN-001, an oral microbiome therapeutic candidate developed to have immune modulating activities. The company also develops GEN-501 targeting the non-responders of Dupilumab drugs with atopic skin diseases; and GENA-104 for the treatment of solid tumors, as well as microbiome-based products, including therapeutics, cosmeceuticals, and dietary supplements. In addition, it has a partnership with US Scioto Biosciences for the development of SB-121, which targets disorders related to the gut-brain axis, such as Autism Spectrum Disorder (ASD), as well as disorders related to gut-injury, including Necrotizing Enterocolitis (NEC). The company was founded in 2015 and is headquartered in Suwon-si, South Korea.
Show More
CEO
Mr. Yoo Seok Hong
Employees
96
Country
South Korea
ISIN
KR7314130006
Listings
0 Comments
Share your thoughts
FAQs
What is Genome & Company stock price today?▼
The current price of 314130.KQ is ₩3,370 KRW — it has decreased by -3.71% in the past 24 hours. Watch Genome & Company stock price performance more closely on the chart.
What is Genome & Company stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange Genome & Company stocks are traded under the ticker 314130.KQ.
Is Genome & Company stock price growing?▼
314130.KQ stock has fallen by -13.59% compared to the previous week, the month change is a -38.73% fall, over the last year Genome & Company has showed a -0.3% decrease.
What is Genome & Company market cap?▼
Today Genome & Company has the market capitalization of 117.59B
What is Genome & Company revenue for the last year?▼
Genome & Company revenue for the last year amounts to 24.59B KRW.
What is Genome & Company net income for the last year?▼
314130.KQ net income for the last year is -6.43B KRW.
How many employees does Genome & Company have?▼
As of November 3, 2026, the company has 96 employees.
In which sector is Genome & Company located?▼
Genome & Company operates in the Other sector.
When did Genome & Company complete a stock split?▼
The last stock split for Genome & Company was on August 6, 2024 with a ratio of 1:1.
Where is Genome & Company headquartered?▼
Genome & Company is headquartered in Suwon-si, South Korea.